Deletion of Murine SMN Exon 7 Directed to Skeletal Muscle Leads to Severe Muscular Dystrophy

Spinal muscular atrophy (SMA) is characterized by degeneration of motor neurons of the spinal cord associated with muscle paralysis and caused by mutations of the survival motor neuron gene (SMN). To determine whether SMN gene defect in skeletal muscle might have a role in SMA pathogenesis, deletion of murine SMN exon 7, the most frequent mutation found in SMA, has been restricted to skeletal muscle by using the Cre-loxP system. Mutant mice display ongoing muscle necrosis with a dystrophic phenotype leading to muscle paralysis and death. The dystrophic phenotype is associated with elevated levels of creatine kinase activity, Evans blue dye uptake into muscle fibers, reduced amount of dystrophin and upregulation of utrophin expression suggesting a destabilization of the sarcolemma components. The mutant mice will be a valuable model for elucidating the underlying mechanism. Moreover, our results suggest a primary involvement of skeletal muscle in human SMA, which may contribute to motor defect in addition to muscle denervation caused by the motor neuron degeneration. These data may have important implications for the development of therapeutic strategies in SMA.

[1]  Fricker,et al.  Mouse model of spinal muscular atrophy. , 2000, Drug discovery today.

[2]  P Miniou,et al.  Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. , 2000, Human molecular genetics.

[3]  U. Monani,et al.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. , 2000, Human molecular genetics.

[4]  Hung Li,et al.  A mouse model for spinal muscular atrophy , 2000, Nature Genetics.

[5]  K. Campbell,et al.  Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. , 2000, Molecular cell.

[6]  J. Melki,et al.  Gene targeting restricted to mouse striated muscle lineage. , 1999, Nucleic acids research.

[7]  H. Hama,et al.  Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. , 1999, Human molecular genetics.

[8]  G. Dreyfuss,et al.  A Novel Function for SMN, the Spinal Muscular Atrophy Disease Gene Product, in Pre-mRNA Splicing , 1998, Cell.

[9]  John A. Faulkner,et al.  Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.

[10]  E. Engvall,et al.  Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. , 1998, The Journal of clinical investigation.

[11]  J. Melki,et al.  Spinal muscular atrophy. , 1997, Current opinion in neurology.

[12]  G. Dreyfuss,et al.  The SMN–SIP1 Complex Has an Essential Role in Spliceosomal snRNP Biogenesis , 1997, Cell.

[13]  A. Smith,et al.  Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Dreyfuss,et al.  A novel nuclear structure containing the survival of motor neurons protein. , 1996, The EMBO journal.

[15]  J. Warter,et al.  Constitutive muscular abnormalities in culture in spinal muscular atrophy , 1995, The Lancet.

[16]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[17]  T. Munsat.  International SMA Collaboration , 1991, Neuromuscular Disorders.

[18]  N. Henderson,et al.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Henderson,et al.  Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons , 1987, Neurology.

[20]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Sanes.  Laminin, fibronectin, and collagen in synaptic and extrasynaptic portions of muscle fiber basement membrane , 1982, The Journal of cell biology.

[22]  N. Sternberg,et al.  Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. , 1981, Journal of molecular biology.

[23]  G. Wijngaarden,et al.  Spinal muscular atrophy and hypertrophy of the calves , 1980, Journal of the Neurological Sciences.

[24]  F. Mastaglia,et al.  Histological and histochemical changes in skeletal muscle from cases of chronic juvenile and early adult spinal muscular atrophy (the Kugelberg-Welander syndrome). , 1971, Journal of the neurological sciences.

[25]  D Grob,et al.  Chronic proximal spinal muscular atrophy. , 1970, Journal of the neurological sciences.

[26]  D. Harriman,et al.  Chronic spinal muscular atrophy , 1966 .

[27]  E. Kugelberg,et al.  Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. , 1956, A.M.A. archives of neurology and psychiatry.